• 1. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
• 2. Distributed research: a new paradigm for undergraduate research and global problem solving?
  Bruce Parkinson Energy Environ. Sci., 2010,3, 509-511
• 3. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
• 4. Excitonic channels from bio-inspired templated supramolecular assembly of J-aggregate nanowires?
  Daniel Messmer,Stefan Salentinig,Jakob Heier Nanoscale, 2019,11, 6929-6938
• 5. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Thiazolecarboxylic acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Thiazoles Thiazolecarboxylic acids and derivatives

Introduction to 5-Methylthiazole-4-carboxylic Acid (CAS No: 120237-76-5)

5-Methylthiazole-4-carboxylic acid, identified by its Chemical Abstracts Service (CAS) number 120237-76-5, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the thiazole derivatives, a class of molecules known for their diverse biological activities and potential therapeutic applications. The structural framework of 5-Methylthiazole-4-carboxylic acid consists of a thiazole ring substituted with a methyl group at the 5-position and a carboxylic acid functional group at the 4-position, which contributes to its unique chemical properties and reactivity.

The synthesis and characterization of 5-Methylthiazole-4-carboxylic acid have been extensively studied due to its promising role as a building block in the development of novel pharmaceutical agents. The carboxylic acid moiety provides a site for further functionalization, enabling the attachment of various pharmacophores or bioactive groups. This flexibility makes it a valuable intermediate in organic synthesis, particularly in the construction of more complex molecules with tailored biological activities.

Recent advancements in the field of medicinal chemistry have highlighted the importance of thiazole derivatives in addressing various therapeutic challenges. 5-Methylthiazole-4-carboxylic acid has been explored for its potential in multiple pharmacological pathways, including antimicrobial, anti-inflammatory, and anticancer applications. The thiazole core is known to interact with biological targets such as enzymes and receptors, modulating cellular processes that are relevant to disease mechanisms.

In particular, studies have demonstrated the compound's ability to inhibit certain enzymes involved in microbial metabolism, showcasing its antimicrobial potential. The presence of the carboxylic acid group allows for further derivatization, which can enhance its binding affinity to specific microbial targets. This has led to investigations into its efficacy against resistant strains of bacteria, making it a subject of interest for developing new antibiotics.

The anti-inflammatory properties of 5-Methylthiazole-4-carboxylic acid have also been examined in preclinical studies. Thiazole derivatives are known to modulate inflammatory pathways by interacting with key signaling molecules such as NF-κB and COX enzymes. By inhibiting these pathways, 5-Methylthiazole-4-carboxylic acid may help reduce inflammation and associated symptoms in conditions like rheumatoid arthritis and inflammatory bowel disease.

Moreover, the anticancer potential of this compound has been explored through various in vitro and in vivo assays. Research suggests that 5-Methylthiazole-4-carboxylic acid can induce apoptosis in cancer cells by disrupting mitochondrial function and inhibiting key survival pathways. Its ability to selectively target cancer cells while minimizing toxicity to healthy cells makes it an attractive candidate for further development into an anticancer therapeutic.

The chemical properties of 5-Methylthiazole-4-carboxylic acid also make it a useful tool in biochemical research. The carboxylic acid group can be used to form esters or amides, which are common modifications in drug design. Additionally, the thiazole ring can participate in coordination chemistry, allowing for the development of metal-based complexes with potential therapeutic applications.

In conclusion, 5-Methylthiazole-4-carboxylic acid (CAS No: 120237-76-5) represents a significant compound in pharmaceutical research due to its structural versatility and biological activity. Its role as an intermediate in drug synthesis and its potential applications in antimicrobial, anti-inflammatory, and anticancer therapies underscore its importance in medicinal chemistry. As research continues to uncover new insights into its mechanisms of action, 5-Methylthiazole-4-carboxylic acid is poised to contribute significantly to the development of next-generation pharmaceutical agents.

• 261710-79-6(5-methyl-1,3-thiazole-4-carbaldehyde)
• 688064-14-4(2-Amino-5-methylthiazole-4-carboxylic acid)
• 87764-55-4(4-Thiazolecarboxylicacid, 5-ethenyl-)
• 22358-80-1(4,5-Thiazoledicarboxylicacid)
• 61323-26-0(Ethyl 5-methylthiazole-4-carboxylate)
• 848774-94-7((5-methyl-1,3-thiazol-4-yl)methanol hydrochloride)
• 188891-43-2(4-Thiazolecarboxylicacid, 5-(hydroxymethyl)-)
• 113366-73-7(dimethyl-1,3-thiazole-4-carboxylic acid)
• 864437-40-1(5-ethyl-1,3-thiazole-4-carboxylic acid)
• 68751-05-3(Methyl 5-methylthiazole-4-carboxylate)